Breaking News

You are here » Indian-Commodity  :  Commodities  :  Jeera  :  Jeera futures trade tad lower on higher arrivals

28-Mar2018

Jeera futures trade tad lower on higher arrivals

Jeera futures traded marginally lower on NCDEX, due to higher arrivals in the physical markets amid bumper acreage.

The contract for April delivery was trading at Rs 14400.00, down by 0.79 % or Rs 115.00 from its previous closing of Rs 14515.00. The open interest of the contract stood at 7515 lots.

The contract for May delivery was trading at Rs 14880.00, down by 0.50 % or Rs 75.00 from its previous closing of Rs 14955.00. The open interest of the contract stood at 1386 lots on NCDEX.








Related News

View all news

Jeera futures trade lower on profit booking

Jeera futures traded lower on NCDEX, due to profit booking by participants after the prices peaked counting on improving physical domestic and exports demands from China and Bangladesh. Moreover, anticipation......

Jeera futures trade higher on firm demand

Jeera futures traded higher on NCDEX, due to scanty rainfall in producing centres of Gujarat and Rajasthan, which might impact cumin production this year. Moreover, firm spot demand from domestic......

Jeera futures trade up on NCDEX

Jeera futures traded up on NCDEX, due to concerns on impact of overall output amid water shortage in producing centres of Gujarat and Rajasthan. Besides, pick-up in demand from domestic and exports markets......

Top News

View all news

Aurobindo Pharma, TVS Motor and Lupin to see some action today

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc., has entered into an agreement to acquire a product under development and related assets from 'Advent Pharmaceuticals Pty, Australia,......

TVS Motor launches TVS Apache RTR 160 4V in Bangladesh

TVS Motor Company has launched the TVS Apache RTR 160 4V in Bangladesh. A testimony to the racing legacy of the TVS Apache RTR series, the TVS Apache RTR 160 4V will be the flagship offering of the brand......

Aurobindo Pharma's arm enters into agreement with Advent Pharma

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc. -- has entered into an agreement to acquire a product under development and related assets from Advent Pharmaceuticals Pty, Australia,......